AXQ Capital LP Has $515,000 Stock Position in Teleflex Incorporated (NYSE:TFX)

AXQ Capital LP decreased its holdings in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 39.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,892 shares of the medical technology company's stock after selling 1,904 shares during the quarter. AXQ Capital LP's holdings in Teleflex were worth $515,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in TFX. HighTower Advisors LLC lifted its stake in shares of Teleflex by 1.7% during the 3rd quarter. HighTower Advisors LLC now owns 3,998 shares of the medical technology company's stock worth $986,000 after buying an additional 66 shares during the last quarter. Hengehold Capital Management LLC raised its holdings in Teleflex by 7.3% in the 4th quarter. Hengehold Capital Management LLC now owns 1,289 shares of the medical technology company's stock valued at $229,000 after acquiring an additional 88 shares during the period. Exchange Traded Concepts LLC lifted its position in Teleflex by 38.2% during the fourth quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company's stock worth $61,000 after acquiring an additional 94 shares during the last quarter. Avior Wealth Management LLC boosted its holdings in shares of Teleflex by 190.6% during the third quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company's stock worth $38,000 after acquiring an additional 101 shares during the period. Finally, Isthmus Partners LLC boosted its holdings in shares of Teleflex by 7.3% during the fourth quarter. Isthmus Partners LLC now owns 1,535 shares of the medical technology company's stock worth $273,000 after acquiring an additional 105 shares during the period. 95.62% of the stock is owned by institutional investors.

Remove Ads

Analyst Ratings Changes

Several analysts recently weighed in on the company. Wells Fargo & Company dropped their price target on Teleflex from $214.00 to $146.00 and set an "equal weight" rating for the company in a report on Friday, February 28th. Raymond James downgraded Teleflex from an "outperform" rating to a "market perform" rating in a report on Friday, February 28th. Truist Financial decreased their price target on shares of Teleflex from $200.00 to $149.00 and set a "hold" rating on the stock in a research note on Monday, March 3rd. Citizens Jmp cut shares of Teleflex from an "outperform" rating to a "market perform" rating in a research note on Thursday, February 27th. Finally, Bank of America lowered shares of Teleflex from a "neutral" rating to an "underperform" rating and decreased their target price for the stock from $235.00 to $140.00 in a research report on Tuesday, March 4th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $182.63.

Teleflex Price Performance

Shares of Teleflex stock traded down $0.89 on Thursday, reaching $139.34. 838,993 shares of the stock were exchanged, compared to its average volume of 554,451. The firm's 50 day moving average is $160.91 and its 200-day moving average is $191.86. The firm has a market cap of $6.46 billion, a PE ratio of 27.70, a P/E/G ratio of 1.73 and a beta of 1.21. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. Teleflex Incorporated has a one year low of $128.55 and a one year high of $249.91.

Teleflex (NYSE:TFX - Get Free Report) last released its earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, topping the consensus estimate of $3.86 by $0.03. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The firm had revenue of $795.40 million during the quarter, compared to analysts' expectations of $813.24 million. As a group, analysts anticipate that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Friday, March 7th were paid a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 0.98%. The ex-dividend date of this dividend was Friday, March 7th. Teleflex's payout ratio is 95.77%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.